Top news of the week: 26.01.2022.
Startups
Billionaires Bankroll Cell Rejuvenation Tech as the Latest Gambit to Slow Aging
Startups bet that carefully controlled cell reprogramming may lead to age reversal, but hurdles remain
Review: Venture capital is a victim of own success
What’s good for venture capital isn’t necessarily good for venture capitalists. That’s one message from “The Power Law: Venture Capital and the Art of Disruption”, Sebastian Mallaby’s ...
In biopharma VC world, what does it mean to take a 'leap'? For Leaps by Bayer, it's 'fewer, but maybe bigger bets'
Sparking innovation at a Big Pharma with a 150-year history can be difficult, so sometimes it takes some outside perspective to get the ball rolling. That's where Leaps by Bayer comes in.
Bayer leads $80M funding round for Cellino, betting on new cell therapy manufacturing platform
Leaps by Bayer is leading an $80 million series A financing round for Cellino Biotech, which offers a more hands-off approach to stem cell therapy manufacturing, combining biology, laser ...
Ex-Massport executive tries to replicate agency’s success to diversify the biotech industry
Bold Types is a weekly look at the movers and shakers in Boston's business scene.
Moderna-partnered gene editor Metagenomi adds $175M to crown from Bayer, BMS and others to get into clinic, launch new biotechs
Bayer and Moderna have already signaled confidence in Metagenomi's CRISPR gene editing. Now, Bristol Myers Squibb, Novo Nordisk and a crop of VC shops have also made a $175 million bet on ...
Chutes & Ladders—GlaxoSmithKline's chief science officer Barron departs for Bezos-backed startup
After four years at chief scientific officer at GlaxoSmithKline, Hal Barron will hit the exit this summer to be CEO of a $3 billion startup, Altos Labs, which counts Jeff Bezos as an ...
Does the world need more COVID-19 vaccines? These companies think there's still room for improvement
The ultimate COVID-19 vaccine will be able to tackle all emerging coronavirus strains, easy to store and quick to manufacture. And yes, there's still time for the stragglers who were beaten ...